Hope for transplant patients after world-first Queensland immunotherapy trial

Published: Comments:
Community Health & Wellness Science & Research

Social:   
The Coordinator of QIMR Berghofer’s Centre for Immunotherapy and Vaccine Development, Professor Rajiv Khanna.

Organ transplant patients who face a lifetime of medication to ward off viral infection – or the potentially deadly threat of drug-resistant infection – may have new hope following a world-first clinical trial that uses a patient’s own immune cells as the treatment.

The immunotherapy treatment involved taking blood from patients, effectively training their killer T (immune) cells to destroy the cytomegalovirus (CMV) and reinfusing the cells into sick patients.

QIMR Berghofer Medical Research Institute’s world-leading immunologist, Professor Rajiv Khanna, led the clinical trial, which treated 13 organ transplant patients with a potentially life-threatening cytomegalovirus infection using their own immune cells.

The Phase 1 clinical trial started in 2014 in conjunction with Associate Professor Scott Campbell at Brisbane’s Princess Alexandra Hospital and Professor Dan Chambers at Brisbane’s Prince Charles Hospital, as well as doctors at the Royal Adelaide Hospital.

Professor Khanna, who is also the coordinator of QIMR Berghofer’s Centre for Immunotherapy and Vaccine Development, developed the immunotherapy treatment by using killer T (immune) cells from patients and training them to recognise and destroy the virus.

He said the phase 1 clinical trial showed the T cell therapy for existing or drug-resistant cytomegalovirus was safe and had provided a clinical benefit to some patients.

Eleven patients showed improved symptoms following the immunotherapy, and some of those patients were able to reduce or stop taking anti-viral medication altogether.

“The patients we treated were quite sick from the complications caused by cytomegalovirus, which is an infection experienced by some organ transplant recipients,” Professor Khanna said.

Associate Professor Campbell said that typically, a patient who has had an organ transplant received drugs to protect them from cytomegalovirus.

“But taking those drugs long-term means that some patients can develop a drug-resistant strain of the virus, and develop cytomegalovirus-associated complications due to their weakened immune system,” Associate Professor Campbell said.

“The anti-viral drugs designed to prevent and treat cytomegalovirus also have many other unpleasant or dangerous side-effects that can lead to severe illness, and can even make it impossible to continue using the drug.”

Professor Chambers said the killer T cell immunotherapy may in future provide doctors with another option to treat very unwell patients.

“We believe the treatment has potentially saved the lives of some patients,” Professor Chambers said.

Professor Khanna said the group had now developed a new, expanded and improved version of the therapy, and planned to commence a clinical trial next year, in collaboration with several clinical centres around Australia.

He said the new version of the immunotherapy also aimed to treat other viral infections that are common in solid organ transplant patients.

QIMR Berghofer’s Director and CEO, Professor Frank Gannon, said the immunotherapy was produced in-house at the Institute’s cell manufacturing facility, Q-Gen Cell Therapeutics.

“These early results are extremely promising and we hope in future it will provide a new and routine way to treat transplant patients who become sick as a result of cytomegalovirus infection,” he said.

The QIMR Berghofer-led research has been published today in the journal Clinical Infectious Diseases and was made possible with funding from the National Health and Medical Research Council.

The journal article is available online here: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciy549/5049442

 
QIMR Berghofer Medical Research Institute :
PO Royal Brisbane Hospital, Brisbane, QLD, 4029, Brisbane
07 3845 3752
QIMR Berghofer Medical Research Institute
Showing 10+ recent articles for this business
World's largest genetic study of cannabis use identifies 35 genes 28 August 2018 | An international team of researchers has conducted the biggest ever study into genetic predisposition for cannabis use and identified 35 genes that influence whether people are likely to ever use the drug. More information...
Hope for transplant patients after world-first Queensland immunotherapy trial 06 July 2018 | Organ transplant patients who face a lifetime of medication to ward off viral infection – or the potentially deadly threat of drug-resistant infection – may have new hope following a world-first clinical trial... More information...
Major study uncovers new breast cancer genes and opens the door for more discoveries 19 June 2018 | An international team of researchers has used a new scientific method to discover at least 12 new genes that influence the risk of developing breast cancer. More information...
Cancer a hit to the heart and the back pocket 11 June 2018 | One quarter of Queenslanders diagnosed with cancer will pay upfront doctors’ fees of more than $20,000 in the first two years, according to a new study shining a light on out-of-pocket costs for survivors. More information...
New genetic markers could help predict onset of debilitating eye disease 15 May 2018 | Scientists have discovered 19 new genetic markers that could predict whether a person is at a higher risk of eye disease. More information...
Researchers uncover how infant viral infections become childhood asthma 10 May 2018 | We have been able to show that young mice with a respiratory virus produce a cell messenger called prostaglandin 2 that actually makes it harder for their immune system to clear the viral infection. More information...
Global genetic study of skin colour unearths 14 new genetic markers 09 May 2018 | Scientists have doubled the number of genetic markers known to influence the ability of a person’s skin to tan. More information...
9 in 10 Australians don't know when they need sun protection 19 March 2018 | Australians could be unknowingly increasing their skin cancer risk, with new data released by Cancer Council today showing that 40 percent of Australians are still confused about which weather factors cause... More information...
Scientists identify new possibility for untreatable blood cancer 16 March 2018 | Scientists have discovered a new biomarker that could help to unlock the medical mystery behind an untreatable blood cancer that affects mostly older Australians. More information...
Online risk predictor to help identify people at high risk of melanoma 12 March 2018 | Researchers at QIMR Berghofer Medical Research Institute have developed an online test for people aged 40 and over to predict their risk of developing melanoma over the next 3.5 years. More information...



Social:   
comments powered by Disqus

All articles submitted by third parties or written by My Sunshine Coast come under our Disclaimer / Terms of Service